Brief: HCW Biologics Regains Compliance With All Continued Listing Rules For Nasdaq Per Nasdaq Determination Letter
02/03/2026 13:29
March 2 (Reuters) - HCW Biologics Inc HCWB.O: HCW BIOLOGICS REGAINS COMPLIANCE WITH ALL CONTINUED LISTING RULES FOR NASDAQ PER NASDAQ DETERMINATION LETTER Source text: ID:nGNX5N2VpG Further company coverage: HCWB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM